86 related articles for article (PubMed ID: 21135152)
1. Need for clarification of data in a recent meta-analysis about TP53 codon 72 polymorphism and cancer susceptibility.
Lu PH; Wei MX; Li C; Shen W; Chen MB
Carcinogenesis; 2011 Mar; 32(3):443; author reply 444. PubMed ID: 21135152
[No Abstract] [Full Text] [Related]
2. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
[TBL] [Abstract][Full Text] [Related]
3. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of epidemiological studies of association of P53 codon 72 polymorphism with bladder cancer.
Li DB; Wei X; Jiang LH; Wang Y; Xu F
Genet Mol Res; 2010 Aug; 9(3):1599-605. PubMed ID: 20730711
[TBL] [Abstract][Full Text] [Related]
5. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
Parhar P; Ezer R; Shao Y; Allen JC; Miller DC; Newcomb EW
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):98-103. PubMed ID: 15950766
[TBL] [Abstract][Full Text] [Related]
6. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
[TBL] [Abstract][Full Text] [Related]
7. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
Jiang P; Liu J; Zeng X; Li W; Tang J
Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
[TBL] [Abstract][Full Text] [Related]
8. Eligible and not eligible studies in the recent meta-analysis about p53 polymorphism and breast cancer risk.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Feb; 120(1):261-2. PubMed ID: 19760041
[No Abstract] [Full Text] [Related]
9. Need for clarification of data in the recent meta-analysis about p53 polymorphism and gastric cancer risk.
Economopoulos KP; Sergentanis TN
Int J Cancer; 2010 May; 126(10):2509. PubMed ID: 19739120
[No Abstract] [Full Text] [Related]
10. p53 codon 72 polymorphism as a risk factor in the development of breast cancer.
Papadakis EN; Dokianakis DN; Spandidos DA
Mol Cell Biol Res Commun; 2000 Jun; 3(6):389-92. PubMed ID: 11032762
[TBL] [Abstract][Full Text] [Related]
11. Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis.
Hu Z; Li X; Qu X; He Y; Ring BZ; Song E; Su L
Carcinogenesis; 2010 Apr; 31(4):643-7. PubMed ID: 20089604
[TBL] [Abstract][Full Text] [Related]
12. Influence of the TP53 codon 72 polymorphism on the cellular responses to X-irradiation in fibroblasts from nonagenarians.
den Reijer PM; Maier AB; Westendorp RG; van Heemst D
Mech Ageing Dev; 2008 Apr; 129(4):175-82. PubMed ID: 18272203
[TBL] [Abstract][Full Text] [Related]
13. Re: Jiang et al.: Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk (Urology 2010;76:765).
Sergentanis TN; Economopoulos KP
Urology; 2011 Jan; 77(1):259-60. PubMed ID: 21195855
[No Abstract] [Full Text] [Related]
14. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
[TBL] [Abstract][Full Text] [Related]
15. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
[TBL] [Abstract][Full Text] [Related]
16. Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma.
Giuliani L; Jaxmar T; Casadio C; Gariglio M; Manna A; D'Antonio D; Syrjanen K; Favalli C; Ciotti M
Lung Cancer; 2007 Sep; 57(3):273-81. PubMed ID: 17400331
[TBL] [Abstract][Full Text] [Related]
17. TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer.
Rogounovitch TI; Saenko VA; Ashizawa K; Sedliarou IA; Namba H; Abrosimov AY; Lushnikov EF; Roumiantsev PO; Konova MV; Petoukhova NS; Tchebotareva IV; Ivanov VK; Chekin SY; Bogdanova TI; Tronko MD; Tsyb AF; Thomas GA; Yamashita S
Oncol Rep; 2006 Apr; 15(4):949-56. PubMed ID: 16525684
[TBL] [Abstract][Full Text] [Related]
18. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
[TBL] [Abstract][Full Text] [Related]
19. TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
Idbaih A; Boisselier B; Marie Y; El Hallani S; Sanson M; Crinière E; Rodero M; Carpentier C; Paris S; Laigle-Donadey F; Ducray F; Hoang-Xuan K; Delattre JY
Cancer Genet Cytogenet; 2007 Sep; 177(2):103-7. PubMed ID: 17854663
[TBL] [Abstract][Full Text] [Related]
20. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients.
Bau DT; Tsai MH; Lo YL; Hsu CM; Tsai Y; Lee CC; Tsai FJ
Anticancer Res; 2007; 27(3B):1559-64. PubMed ID: 17595776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
